formamide has been researched along with Lupus Erythematosus, Systemic in 1 studies
formimidic acid : A carboximidic acid that is formic acid in which the carbonyl oxygen is replaced by an imino group.
primary carboxamide : A carboxamide resulting from the formal condensation of a carboxylic acid with ammonia; formula RC(=O)NH2.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, ZY | 1 |
| Chen, SH | 1 |
| Cheng, JP | 1 |
| Zhou, WX | 1 |
| Zhang, YX | 1 |
| Yang, RF | 1 |
| Yun, LH | 1 |
1 other study available for formamide and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
Topics: Administration, Oral; Adoptive Transfer; Animals; Autoantibodies; Chronic Disease; Enzyme-Linked Imm | 2012 |